5
Leave a Reply

5 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
3 Comment authors
PeterGregory D. PawelskiTom Leith Recent comment authors
newest oldest most voted
Gregory D. Pawelski
Guest
Gregory D. Pawelski

Cancer docs profit from chemotherapy drugs
The situation begs the ethical question: Are they overprescribing?
NBC News
September 21, 2006
http://www.msnbc.msn.com/id/14944098/

Gregory D. Pawelski
Guest
Gregory D. Pawelski

I know it’s frustrating after twenty some years being used to such a high level of income, only having to come back down to equal keel with most other physicians.
And the Associations and Societies that sprung up to support the network of specialties, don’t seem to be making their “talking-points” pointive-enough anymore.
I believe the so-called leader of the free world said once: “Fool me once, shame on you-fool me-you can’t get fooled again.”

Peter
Guest
Peter

Don’t docs just love those government entitlement programs. Why does everything in healthcare seem to turn out to be just another method to “game” the system.

Gregory D. Pawelski
Guest
Gregory D. Pawelski

Yes, in 2005, CMS initiated a one-year demonstration project for cancer patients undergoing chemotherapy. The demonstration focused on measuring patient outcomes in three areas of concern often cited by patients undergoing infusional chemotherapy: controlling pain; minimizing nausea and vomiting; and reducing fatigue. Oncology Practices reporting data on all three factors qualified for an additional payment of $130 per encounter for chemotherapy administration (a financial incentive to use infusional drugs over oral drugs). That included a $26 patient copay. A Republican, Senate Finance Committee Chairman Chuck Grassley, found out from the Health and Human Services’ inspector general’s office that the value… Read more »

Tom Leith
Guest
Tom Leith

Sen. Charles Grassley R-Iowa, said taxpayers and beneficiaries were “bilked” because they paid for services that physicians are already supposed to provide. So, Senator Grassley thinks that docs are supposed to be reporting outcome data to someone already? What’s he smoking? I don’t think its quite right that the Medicare beneficiaries paid the customary 20% — seems to me there was an oversight in the billing process. I can understand why a program like this gets spun-up and I’m not defending the way it might have been run, but I think I’m with CMS on this one. Somehow we must… Read more »